DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Zaja F, Baccarani M, Mazza P , et al.
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
Blood 2010;
115 (14) 2755-2762
We do not assume any responsibility for the contents of the web pages of other providers.